[
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions",
    "summary": "Medical device leaders counter tariff pressures with innovation, as AI adoption and aging demographics support long-term growth.",
    "url": "https://finnhub.io/api/news?id=074ef44b244ed393a78b855792b4046a0d6f9db9ccf81ba909a3e639cd7c440c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770138120,
      "headline": "Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions",
      "id": 138345652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Medical device leaders counter tariff pressures with innovation, as AI adoption and aging demographics support long-term growth.",
      "url": "https://finnhub.io/api/news?id=074ef44b244ed393a78b855792b4046a0d6f9db9ccf81ba909a3e639cd7c440c"
    }
  },
  {
    "ts": null,
    "headline": "Silver Economy Boom: Investing in Healthcare's Aging Tailwinds",
    "summary": "An aging population is reshaping healthcare, with BSX, RMD, ABBV and AMGN positioned to benefit from rising senior care demand.",
    "url": "https://finnhub.io/api/news?id=86913971a38664fa1f8c01de5e87a4832c1200b2daafc58749a3c5d3986040d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770135480,
      "headline": "Silver Economy Boom: Investing in Healthcare's Aging Tailwinds",
      "id": 138344914,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "An aging population is reshaping healthcare, with BSX, RMD, ABBV and AMGN positioned to benefit from rising senior care demand.",
      "url": "https://finnhub.io/api/news?id=86913971a38664fa1f8c01de5e87a4832c1200b2daafc58749a3c5d3986040d2"
    }
  },
  {
    "ts": null,
    "headline": "4 Medical Product Stocks to Watch From a Challenging Industry (Revised)",
    "summary": "The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
    "url": "https://finnhub.io/api/news?id=6a5cb66c5afe5a21fb02f8dd0209293dfd7f880330f8a8712ba4e78d03be9d7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770115020,
      "headline": "4 Medical Product Stocks to Watch From a Challenging Industry (Revised)",
      "id": 138340783,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "The Zacks Medical Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
      "url": "https://finnhub.io/api/news?id=6a5cb66c5afe5a21fb02f8dd0209293dfd7f880330f8a8712ba4e78d03be9d7a"
    }
  },
  {
    "ts": null,
    "headline": "ResMed Inc. (RMD): A Bull Case Theory",
    "summary": "We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.’s share was trading at $257.61 as of January 29th. RMD’s trailing and forward P/E were 26.38 and 23.70 respectively according to Yahoo Finance. ResMed Inc. develops, manufactures, distributes, and markets […]",
    "url": "https://finnhub.io/api/news?id=c55b67a5b69bab47e0881bcd047f3d10385b49713863ae0dce7f3f7272fa80bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770083618,
      "headline": "ResMed Inc. (RMD): A Bull Case Theory",
      "id": 138338080,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.’s share was trading at $257.61 as of January 29th. RMD’s trailing and forward P/E were 26.38 and 23.70 respectively according to Yahoo Finance. ResMed Inc. develops, manufactures, distributes, and markets […]",
      "url": "https://finnhub.io/api/news?id=c55b67a5b69bab47e0881bcd047f3d10385b49713863ae0dce7f3f7272fa80bc"
    }
  }
]